These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 33110915)

  • 1. Mesenchymal stem cell treatment in a critically ill COVID-19 patient: a case report.
    Zengin R; Beyaz O; Koc ES; Akinci IO; Kocagoz S; Sagcan G; Ovali E; Cuhadaroglu C
    Stem Cell Investig; 2020; 7():17. PubMed ID: 33110915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compassionate mesenchymal stem cell treatment in a severe COVID-19 patient: a case report.
    Primorac D; Stojanović Stipić S; Strbad M; Girandon L; Barlič A; Frankić M; Ivić I; Marasović Krstulović D; Jukić I; Halassy B; Hećimović A; Matišić V; Molnar V
    Croat Med J; 2021 Jun; 62(3):288-296. PubMed ID: 34212566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulatory and Anti-fibrotic Effects Following the Infusion of Umbilical Cord Mesenchymal Stromal Cells in a Critically Ill Patient With COVID-19 Presenting Lung Fibrosis: A Case Report.
    da Silva KN; Pinheiro PCG; Gobatto ALN; Passos RDH; Paredes BD; França LSA; Nonaka CKV; Barreto-Duarte B; Araújo-Pereira M; Tibúrcio R; Cruz FF; Martins GLS; Andrade BB; de Castro-Faria-Neto HC; Rocco PRM; Souza BSF
    Front Med (Lausanne); 2021; 8():767291. PubMed ID: 34869480
    [No Abstract]   [Full Text] [Related]  

  • 4. Could Mesenchymal Stem Cell-Derived Exosomes Be a Therapeutic Option for Critically Ill COVID-19 Patients?
    Gardin C; Ferroni L; Chachques JC; Zavan B
    J Clin Med; 2020 Aug; 9(9):. PubMed ID: 32858940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspectives on mesenchymal stem/progenitor cells and their derivates as potential therapies for lung damage caused by COVID-19.
    Klimczak A
    World J Stem Cells; 2020 Sep; 12(9):1013-1022. PubMed ID: 33033561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases.
    Tsuchiya A; Takeuchi S; Iwasawa T; Kumagai M; Sato T; Motegi S; Ishii Y; Koseki Y; Tomiyoshi K; Natsui K; Takeda N; Yoshida Y; Yamazaki F; Kojima Y; Watanabe Y; Kimura N; Tominaga K; Kamimura H; Takamura M; Terai S
    Inflamm Regen; 2020; 40():14. PubMed ID: 32582401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Umbilical Cord Mesenchymal Stem Cells for Adjuvant Treatment of a Critically Ill COVID-19 Patient: A Case Report.
    Zhu Y; Zhu R; Liu K; Li X; Chen D; Bai D; Luo J; Liu Y; Zhang Y; Li L; Hu J; Xu D; Liu Y; Zhao RC
    Infect Drug Resist; 2020; 13():3295-3300. PubMed ID: 33061476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Use of Tocilizumab May Prevent Clinical Deterioration in Select COVID-19 Patients: A Case Series.
    Hitawala A; Kumar S; Gopalakrishna KV
    Cureus; 2020 Jul; 12(7):e9187. PubMed ID: 32818119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells - a promising therapy for Acute Respiratory Distress Syndrome.
    Hayes M; Curley G; Laffey JG
    F1000 Med Rep; 2012; 4():2. PubMed ID: 22238514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ruxolitinib Rapidly Reduces Acute Respiratory Distress Syndrome in COVID-19 Disease. Analysis of Data Collection From RESPIRE Protocol.
    Capochiani E; Frediani B; Iervasi G; Paolicchi A; Sani S; Roncucci P; Cuccaro A; Franchi F; Simonetti F; Carrara D; Bertaggia I; Nasso D; Riccioni R; Scolletta S; Valente S; Conticini E; Gozzetti A; Bocchia M
    Front Med (Lausanne); 2020; 7():466. PubMed ID: 32850921
    [No Abstract]   [Full Text] [Related]  

  • 11. Mesenchymal Stem Cell Infusion Shows Promise for Combating Coronavirus (COVID-19)- Induced Pneumonia.
    Shetty AK
    Aging Dis; 2020 Apr; 11(2):462-464. PubMed ID: 32257554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful recovery from critical COVID-19 pneumonia with extracorporeal membrane oxygenation: A case report.
    Ikuyama Y; Wada Y; Tateishi K; Kitaguchi Y; Yasuo M; Ushiki A; Urushihata K; Yamamoto H; Kamijo H; Mita A; Imamura H; Hanaoka M
    Respir Med Case Rep; 2020; 30():101113. PubMed ID: 32523870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case Report: Human Umbilical Cord Mesenchymal Stem Cells as a Therapeutic Intervention for a Critically Ill COVID-19 Patient.
    Zhang Q; Huang K; Lv J; Fang X; He J; Lv A; Sun X; Cheng L; Zhong Y; Wu S; Dai Y
    Front Med (Lausanne); 2021; 8():691329. PubMed ID: 34307417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recovery from COVID-19 and acute respiratory distress syndrome: the potential role of an intensive care unit recovery clinic: a case report.
    Mayer KP; Sturgill JL; Kalema AG; Soper MK; Seif SM; Cassity EP; Hatton Kolpek J; Dupont-Versteegden EE; Montgomery-Yates AA; Morris PE
    J Med Case Rep; 2020 Sep; 14(1):161. PubMed ID: 32912329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Severe COVID-19 with Tocilizumab Mitigates Cytokine Storm and Averts Mechanical Ventilation During Acute Respiratory Distress: A Case Report and Literature Review.
    Farooqi F; Dhawan N; Morgan R; Dinh J; Nedd K; Yatzkan G
    Trop Med Infect Dis; 2020 Jul; 5(3):. PubMed ID: 32635353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Application of mesenchymal stem cell in the treatment of acute respiratory distress syndrome].
    Xu W; Chen W
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Mar; 30(3):275-279. PubMed ID: 29519290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research progress on Mesenchymal Stem Cells (MSCs), Adipose-Derived Mesenchymal Stem Cells (AD-MSCs), Drugs, and Vaccines in Inhibiting COVID-19 Disease.
    Gentile P; Sterodimas A; Pizzicannella J; Calabrese C; Garcovich S
    Aging Dis; 2020 Oct; 11(5):1191-1201. PubMed ID: 33014532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Fourteen-day Experience with Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS): An Iranian Treatment Protocol.
    Jamaati H; Dastan F; Tabarsi P; Marjani M; Saffaei A; Hashemian SM
    Iran J Pharm Res; 2020; 19(1):31-36. PubMed ID: 32922466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal Superimposed Bacterial Sepsis in a Healthy Coronavirus (COVID-19) Patient.
    Jose M; Desai K
    Cureus; 2020 May; 12(5):e8350. PubMed ID: 32617223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute Renal Failure in Critically Ill COVID-19 Patients With a Focus on the Role of Renal Replacement Therapy: A Review of What We Know So Far.
    Raza A; Estepa A; Chan V; Jafar MS
    Cureus; 2020 Jun; 12(6):e8429. PubMed ID: 32642345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.